[PR]まずは試したいあなたに。トライアルサイズも特別価格 >>『PRIME BUY抗体特割キャンペーン(4/21~)

H6PD Recombinant antibody, PBS Only

H6PD Uni-rAbTM Recombinant Antibody for WB, Indirect ELISA
Cat No. 82819-2-PBS
Clone No.3C14

Host / Isotype

Rabbit / IgG

Reactivity

Human, rat

Applications

WB, Indirect ELISA

6PGL, DKFZp686A01246, G6PDH, GDH, H6PD

Formulation:  PBS Only
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -


ご購入について

国内販売は「コスモ・バイオ株式会社」を通じて行っております。お見積り・ご注文はお近くの販売代理店へご連絡ください。


国内在庫・納期について

約2万点のプロテインテック製品をコスモバイオ社物流センター(国内)に在庫しています。国内在庫の有無はコスモバイオ社ホームページの「品番検索」でカタログ番号を検索して確認できます。


保証・サポートについて

テクニカルサポートまたはご購入後1年間の交換/補填対応を承ります。詳細はこちらをご覧ください。


Tested Applications

Recommended dilution

ApplicationDilution
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Product Information

82819-2-PBS targets H6PD in WB, Indirect ELISA applications and shows reactivity with Human, rat samples.

Tested Reactivity Human, rat
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen H6PD fusion protein Ag7109 相同性解析による交差性が予測される生物種
Full Name hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
Calculated molecular weight 89 kDa
Observed molecular weight 89-95 kDa
GenBank accession numberBC081559
Gene Symbol H6PD
Gene ID (NCBI) 9563
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDO95479
Storage Buffer PBS only , pH 7.3
Storage ConditionsStore at -80°C.

Background Information

Hexose-6-phosphate dehydrogenase (H6PD) is also named as GDH,6PGL. It is the main NADPH generating enzyme in the lumen of the endoplasmic reticulum. H6PD is regarded as an ancillary enzyme in prereceptorial glucocorticoid activation and probably acts as a nutrient sensor and as a prosurvival factor(PMID:21620971). H6PD is a glycoprotein and has been shown tissue differences in glycosylation status might explain both the difference in migration on SDS-PAGE gels as well as in activity. Defects in H6PD are a cause of cortisone reductase deficiency (CRD).

Loading...